DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 201 filers reported holding DIPLOMAT PHARMACY INC in Q4 2017. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $77,000 | -36.9% | 19,135 | -23.0% | 0.00% | -100.0% |
Q3 2019 | $122,000 | -12.2% | 24,855 | +8.5% | 0.00% | 0.0% |
Q2 2019 | $139,000 | +4.5% | 22,901 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $133,000 | -70.9% | 22,901 | -32.6% | 0.00% | -50.0% |
Q4 2018 | $457,000 | -22.5% | 33,997 | +11.9% | 0.00% | -33.3% |
Q3 2018 | $590,000 | -29.8% | 30,382 | -7.7% | 0.00% | -25.0% |
Q2 2018 | $841,000 | +22.4% | 32,921 | -3.4% | 0.00% | 0.0% |
Q1 2018 | $687,000 | -9.1% | 34,072 | -9.5% | 0.00% | +33.3% |
Q4 2017 | $756,000 | -12.6% | 37,650 | -9.8% | 0.00% | -25.0% |
Q3 2017 | $865,000 | +44.9% | 41,749 | +3.5% | 0.00% | +33.3% |
Q2 2017 | $597,000 | -7.2% | 40,326 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $643,000 | +49.2% | 40,326 | +17.8% | 0.00% | +50.0% |
Q4 2016 | $431,000 | -55.1% | 34,240 | 0.0% | 0.00% | -60.0% |
Q3 2016 | $959,000 | -2.9% | 34,240 | +21.3% | 0.01% | 0.0% |
Q2 2016 | $988,000 | +86.1% | 28,220 | +45.5% | 0.01% | +66.7% |
Q1 2016 | $531,000 | – | 19,390 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
Investors Research Corp | 89,727 | $546,000 | 0.28% |
Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |